Norwood Financial’s GSK GSK Stock Holding History

Norwood Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$32.4K	Sell	757 -80	-10%	-$3.3K	0.05%	184
2023 Q4	$31K	Hold	837	–	–	0.05%	174
2023 Q3	$30.3K	Sell	837 -100	-11%	-$3.55K	0.05%	171
2023 Q2	$33.4K	Hold	937	–	–	0.05%	165
2023 Q1	$33.3K	Hold	937	–	–	0.05%	159
2022 Q4	$32.9K	Sell	937 -50	-5%	-$1.67K	0.05%	159
2022 Q3	$29K	Buy	987 +195	+25%	+$7.39K	0.05%	162
2022 Q2	$43K	Sell	792 -8	-1%	-$442	0.07%	138
2022 Q1	$43K	Hold	800	–	–	0.06%	149
2021 Q4	$44K	Buy	+800	New	+$41.6K	0.06%	149

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norwood Financial's GSK Position: Q1 2024 in Review

Norwood Financial reduced its GSK (GSK) stake by 9.6% in Q1 2024, selling an estimated $3.3K and leaving 757 shares worth $32.4K. The position accounts for 0.05% of the portfolio, ranked #184.

Norwood Financial first reported a position in GSK in Q4 2021 and has held it in 10 quarters since. The position peaked at $44K in Q4 2021. 911 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

Norwood Financial held 757 shares of GSK worth $32.4K as of Q1 2024.
Norwood Financial sold 80 GSK shares in Q1 2024, an estimated $3.3K.
GSK made up 0.05% of Norwood Financial's portfolio in Q1 2024, its #184 holding.
Norwood Financial first reported a position in GSK in Q4 2021 and has held it in 10 quarters since.
Norwood Financial's GSK position peaked at $44K in Q4 2021.
911 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.